Artificial Pancreas Systems: Evolution, Advanced Control Strategies, and Future Directions in Automated Glucose Management
Abstract Artificial pancreas (AP) systems, also known as automated insulin delivery (AID) systems, represent a significant advancement in the management of type 1 diabetes (T1D) and, increasingly, type 2 diabetes (T2D). These systems integrate continuous […]
